Cipla Q4 profit up 30 pc at Rs 1 222 cr revenue at Rs 6 730 cr

New Delhi, May 13 (PTI) Drug major Cipla on Tuesday said its consolidated net profit increased 30 per cent to Rs 1,222 crore in the fourth quarter ended March 31, 2025.
     The Mumbai-based drug firm had reported a consolidated net profit of Rs 939 crore for the January-March period a year ago.
     Total revenue from operations rose to Rs 6,730 crore in the period under review as compared with Rs 6,163 crore a year ago, Cipla said in a regulatory filing.
     For FY25, the company reported a consolidated net profit of Rs 5,272 crore, up 28 per cent as compared with Rs 4,122 crore in 2023-24. Revenue from operations increased to Rs 27,548 crore from Rs 25,774 crore.
     The company said its board has approved a final dividend of Rs 13 per share for FY25, and a special dividend of Rs 3 per share on the occasion of the drug firm completing 90 years, taking the total dividend to Rs 16 per share of face value of Rs 2 each.
     Shares of the company were trading 0.46 per cent up at Rs 1,519 apiece on BSE.

(This story has not been edited by THE WEEK and is auto-generated from PTI)